UBX
NGSUnity Biotechnology Inc.
Healthcare•Biotechnology
Watchlists:
Last updated: Wednesday 9th July 2025
0.20
-0.10 (-33.41%)
Prev Close:0.3005
Open:0.2824
Bid:0.1764
Ask:0.1799
52 Week Range
0.203.10
Volume:630,069
Mkt Cap:6 M
30
MarketXLS Rank ®
Weak Hold
Price Target
$0.23
+14.9%
Financial Statements
UBX - Income Statement (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Invalid date | |
|---|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | 900000.0 | 1 M | 2 M | 3 M | 3 M | 3 M | -2 M | |
| Gain On Sale Of PPE | 114000.0 | 346000.0 | ||||||
| General And Administrative Expense | 15 M | 19 M | 21 M | 23 M | 24 M | 20 M | 16 M | |
| Gross Profit Margin (profit Margin After CGS) | 5 M | 4 M | 236000.0 | 5 M | ||||
| Impairment Of Capital Assets | 3 M | 6 M | ||||||
| Interest Expense Non Operating | 2 M | 4 M | 3 M | 1 M | ||||
| Interest Expense Operating | -2 M | -2 M | ||||||
| Misc Other Special Charges | -265000.0 | -2 M | -1 M | -983000.0 | 182000.0 | 4 M | -245000.0 | |
| Net Income (loss) | -26 M | -40 M | -44 M | -61 M | -94 M | -82 M | -76 M | |
| Net Income Common Stockholders | -26 M | -40 M | -44 M | -61 M | -94 M | -85 M | -76 M | |
| Net Income Continuous Operations | -26 M | -40 M | -44 M | -61 M | -94 M | -82 M | -76 M | |
| Net Income From Other Gains Losses | -1 M | |||||||
| Net Non Operating Interest Income Expense | 2 M | 422000.0 | -2 M | -3 M | -96000.0 | 3 M | 3 M | |
| Normalized Income | -24 M | |||||||
| Operating Income | -31 M | -45 M | -58 M | -57 M | -94 M | -90 M | -79 M | |
| Operating Income Before Depreciation (EBITDA) | -25 M | -36 M | -37 M | -53 M | -89 M | -83 M | -75 M | |
| Operating Expense | 31 M | 45 M | 58 M | 61 M | 94 M | 90 M | 79 M | |
| Other Gand A | 15 M | 19 M | 21 M | 23 M | 24 M | 20 M | 16 M | |
| Other Impairment Of Capital Assets | 3 M | 6 M | 3 M | 3 M | ||||
| Other Operating Expenses | -33000.0 | -84000.0 | -4 M | -3 M | 33000.0 | 1 M | 5 M | |
| Rent And Landing Fees | -2 M | |||||||
| Research Expense | 13 M | 20 M | 37 M | 38 M | 67 M | 71 M | 59 M | |
| Restructring And Mn A Income | 2 M | |||||||
| Salaries And Wages | 4 M | 7 M | 9 M | -9 M | ||||
| Total Income Available For Interest Expense (EBIT) | -26 M | -37 M | -41 M | -58 M | -93 M | -85 M | -76 M | |
| Total Revenues | 5 M | 4 M | 236000.0 | 5 M | ||||
| Total Expenses | 31 M | 45 M | 58 M | 61 M | 94 M | 90 M | 79 M | |
| Total Revenue | 5 M | 4 M | 236000.0 | 5 M | ||||
| Amord | -2 M | -276000.0 | ||||||
| Avgshs | 17 M | 15 M | 9 M | 6 M | 5 M | 4 M | 3 M | |
| Avgshsdt | 17 M | 15 M | 9 M | 5 M | 4 M | 3 M | ||
| Basiceps | -1.54 | -2.7 | -6.31 | -10.9 | -18.4 | -18.8 | ||
| Basicepscont | -1.54 | -2.7 | -6.31 | -10.9 | -18.4 | -18.8 | ||
| Depamor | 900000.0 | 1 M | 2 M | 3 M | 3 M | 3 M | -2 M | |
| Dileps | -1.54 | -2.7 | -6.31 | -10.9 | -18.4 | -18.8 | -27.0 | |
| Dilepscont | -1.54 | -2.7 | -6.31 | -27.0 | ||||
| Intinc | 2 M | 3 M | 1 M | 100000.0 | 1 M | 3 M | 3 M | |
| Netincdisc | -26 M | -40 M | -44 M | -61 M | -94 M | -82 M | -76 M | |
| Othincexp | 3 M | 7 M | 15 M | 983000.0 | 2 M | -4 M | 245000.0 | |
| Othspecchg | 825000.0 | |||||||
| Pretaxinc | -26 M | -46 M | -44 M | -61 M | -94 M | -85 M | -76 M | |
| Resdev | 13 M | 20 M | 37 M | 38 M | 67 M | 71 M | 59 M | |
| Restruct | 2 M | |||||||
| Sga | 15 M | 19 M | 21 M | 23 M | 24 M | 20 M | 16 M | |
| Shsout | 17 M | 17 M | 14 M | 7 M | 5 M | 5 M | 4 M | |
| Specincchg | -3 M | -6 M | -825000.0 | -2 M |